In the US, QUVIVIQ (daridorexant) CIV 25 mg and 50 mg tablets are indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance1QUVIVIQ
Shares of Idorsia Ltd (OTCMKTS:IDRSF – Get Rating) have been given a consensus rating of “Buy” by the six research firms that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 […]
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - April 26, 2022 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2022. Business highlights PIVLAZ
Ad hoc announcement pursuant to Art. 53 LR All Board proposals approved by the Shareholders Allschwil, Switzerland - April 14, 2022At today's Annual General Meeting (AGM) of Idorsia Ltd (SIX: